Repurposing existing medications to reduce severe acute respiratory distress in patients with COVID-19: the CLARITY trial
- Funded by Australian Government (Australian Research Council)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AKnown Financial Commitments (USD)
$2,550,986.18Funder
Australian Government (Australian Research Council)Research Location
AustraliaLead Research Institution
UNSW SydneyResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementationResearch Subcategory
Prophylactic use of treatmentsSpecial Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
UnspecifiedBroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
MRFF Respiratory Medicine Clinical Trials Research on COVID-19 Grant Opportunity research recipient